BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18437305)

  • 1. Methods to assay inhibitors of tRNA synthetase activity.
    Beyer D; Kroll HP; Brötz-Oesterhelt H
    Methods Mol Med; 2008; 142():53-61. PubMed ID: 18437305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New aminoacyl-tRNA synthetase inhibitors as antibacterial agents.
    Pohlmann J; Brötz-Oesterhelt H
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):261-72. PubMed ID: 15578968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoacyl-tRNA synthetases and their inhibitors as a novel family of antibiotics.
    Kim S; Lee SW; Choi EC; Choi SY
    Appl Microbiol Biotechnol; 2003 May; 61(4):278-88. PubMed ID: 12743756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A series of heterocyclic inhibitors of phenylalanyl-tRNA synthetases with antibacterial activity.
    Yu XY; Finn J; Hill JM; Wang ZG; Keith D; Silverman J; Oliver N
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1343-6. PubMed ID: 14980695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.
    Lv PC; Zhu HL
    Curr Med Chem; 2012; 19(21):3550-63. PubMed ID: 22680640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of beta-ketophosphonate analogs of glutamyl and glutaminyl adenylate, and selective inhibition of the corresponding bacterial aminoacyl-tRNA synthetases.
    Balg C; Blais SP; Bernier S; Huot JL; Couture M; Lapointe J; Chênevert R
    Bioorg Med Chem; 2007 Jan; 15(1):295-304. PubMed ID: 17049867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase.
    Jarvest RL; Erskine SG; Forrest AK; Fosberry AP; Hibbs MJ; Jones JJ; O'Hanlon PJ; Sheppard RJ; Worby A
    Bioorg Med Chem Lett; 2005 May; 15(9):2305-9. PubMed ID: 15837314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of ochratoxin A.
    Dirheimer G; Creppy EE
    IARC Sci Publ; 1991; (115):171-86. PubMed ID: 1820332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review.
    Bouz G; Zitko J
    Bioorg Chem; 2021 May; 110():104806. PubMed ID: 33799176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoacyl-tRNA synthetase inhibitors as potential antibiotics.
    Vondenhoff GH; Van Aerschot A
    Eur J Med Chem; 2011 Nov; 46(11):5227-36. PubMed ID: 21968372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo inhibitors of Escherichia coli phenylalanyl-tRNA synthetase.
    Santi DV; Cunnion SO; Anderson RT; Webster RW
    J Med Chem; 1979 Oct; 22(10):1260-3. PubMed ID: 390149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoacyl-tRNA synthetase inhibitors as antimicrobial agents: a patent review from 2006 till present.
    Gadakh B; Van Aerschot A
    Expert Opin Ther Pat; 2012 Dec; 22(12):1453-65. PubMed ID: 23062029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A homogeneous method to measure aminoacyl-tRNA synthetase aminoacylation activity using scintillation proximity assay technology.
    Macarrón R; Mensah L; Cid C; Carranza C; Benson N; Pope AJ; Díez E
    Anal Biochem; 2000 Sep; 284(2):183-90. PubMed ID: 10964400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.
    Bharatham N; Bharatham K; Lee KW
    J Mol Graph Model; 2007 Mar; 25(6):813-23. PubMed ID: 16996282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity.
    Beyer D; Kroll HP; Endermann R; Schiffer G; Siegel S; Bauser M; Pohlmann J; Brands M; Ziegelbauer K; Haebich D; Eymann C; Brötz-Oesterhelt H
    Antimicrob Agents Chemother; 2004 Feb; 48(2):525-32. PubMed ID: 14742205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoacyl-tRNA synthetase inhibitors as potent and synergistic immunosuppressants.
    Van de Vijver P; Ostrowski T; Sproat B; Goebels J; Rutgeerts O; Van Aerschot A; Waer M; Herdewijn P
    J Med Chem; 2008 May; 51(10):3020-9. PubMed ID: 18438987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the targets of aminoacyl-tRNA synthetase inhibitors by primer extension inhibition.
    Orelle C; Szal T; Klepacki D; Shaw KJ; Vázquez-Laslop N; Mankin AS
    Nucleic Acids Res; 2013 Aug; 41(14):e144. PubMed ID: 23761439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoacyl tRNA synthetases as targets for new anti-infectives.
    Schimmel P; Tao J; Hill J
    FASEB J; 1998 Dec; 12(15):1599-609. PubMed ID: 9837850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A series of spirocyclic analogues as potent inhibitors of bacterial phenylalanyl-tRNA synthetases.
    Yu XY; Finn J; Hill JM; Wang ZG; Keith D; Silverman J; Oliver N
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1339-42. PubMed ID: 14980694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on targeting aminoacyl-tRNA synthetases for the treatment of fungal infections.
    Ferrer E
    Drug News Perspect; 2006; 19(6):347-8. PubMed ID: 16971970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.